Wang B, Hao J, Jones SC, et al. Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart [J]. Am J Physiol Heart Circ Physiol, 2002, 282(5): H1685-H1696.
Xia CF, Bledsoe G, Chao L, et al. Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats [J]. Am J Physiol Renal Physiol, 2005, 289(3): F622-F631.
[9]
Jing L, Zhang JZ, Zhao L, et al. High-expression of transforming growth factor beta1 and phosphorylation of extracellular signal-regulated protein kinase in vascular smooth muscle cells from aorta and renal arterioles of spontaneous hypertension rats [J]. Clin Exp Hypertens, 2007, 29(2): 107.
[10]
Torun D, Ozelsancak R, Turan I, et al. The relationship between obesity and transforming growth factor beta on renal damage in essential hypertension [J]. Int Heart J, 2007, 48(6): 733-741.
Cipollone F, Fazia M, Mincione G, et al. Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques [J]. Stroke, 2004, 35(10): 2253-2257.
Palaniyandi Selvaraj S, Watanabe K, Ma M, et al. Involvement of mast cells in the development of fibrosis in rats with postmyocarditis dilated cardiomyopathy [J]. Biol Pharm Bull, 2005, 28(11): 2128-2132.
Xu J, Cui G, Esmailian F, et al. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation [J]. Circulation, 2004, 109(3): 363-368.
[18]
Everett TH 4th, Olgin JE. Atrial fibrosis and the mechanisms of atrial fibrillation [J]. Heart Rhythm, 2007, 4(3 Suppl): S24-S27.
[19]
Li X, Ma C, Dong J, et al. The fibrosis and atrial fibrillation: is the transforming growth factor-beta1 a candidate etiology of atrial fibrillation [J]. Med Hypotheses, 2008, 70(2): 317-319.
[20]
Verheule S, Sato T, Everett T, et al. Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1 [J]. Circ Res, 2004, 94(11): 1458-1465.